(Q52016510)

English

Prevalence of human erythrovirus B19 DNA in healthy Belgian blood donors and correlation with specific antibodies against structural and non-structural viral proteins.

scientific article

In more languages

Statements

scholarly article

1 reference

Europe PubMed Central

PubMed publication ID

19 April 2018

http://europepmc.org/abstract/MED/12757504

Prevalence of human erythrovirus B19 DNA in healthy Belgian blood donors and correlation with specific antibodies against structural and non-structural viral proteins. (English)

1 reference

Europe PubMed Central

PubMed publication ID

19 April 2018

http://europepmc.org/abstract/MED/12757504

1 reference

based on heuristic

inferred from title

author name string

Thomas I

1

1 reference

Europe PubMed Central

PubMed publication ID

19 April 2018

http://europepmc.org/abstract/MED/12757504

Di Giambattista M

2

1 reference

Europe PubMed Central

PubMed publication ID

19 April 2018

http://europepmc.org/abstract/MED/12757504

Gérard C

3

1 reference

Europe PubMed Central

PubMed publication ID

19 April 2018

http://europepmc.org/abstract/MED/12757504

Mathys E

4

1 reference

Europe PubMed Central

PubMed publication ID

19 April 2018

http://europepmc.org/abstract/MED/12757504

Hougardy V

5

1 reference

Europe PubMed Central

PubMed publication ID

19 April 2018

http://europepmc.org/abstract/MED/12757504

Latour B

6

1 reference

Europe PubMed Central

PubMed publication ID

19 April 2018

http://europepmc.org/abstract/MED/12757504

Branckaert T

7

1 reference

Europe PubMed Central

PubMed publication ID

19 April 2018

http://europepmc.org/abstract/MED/12757504

Laub R

8

1 reference

Europe PubMed Central

PubMed publication ID

19 April 2018

http://europepmc.org/abstract/MED/12757504

publication date

1 May 2003

1 reference

Europe PubMed Central

PubMed publication ID

19 April 2018

http://europepmc.org/abstract/MED/12757504

1 reference

Europe PubMed Central

PubMed publication ID

19 April 2018

http://europepmc.org/abstract/MED/12757504

84

1 reference

Europe PubMed Central

PubMed publication ID

19 April 2018

http://europepmc.org/abstract/MED/12757504

4

1 reference

Europe PubMed Central

PubMed publication ID

19 April 2018

http://europepmc.org/abstract/MED/12757504

300-307

1 reference

Europe PubMed Central

PubMed publication ID

19 April 2018

http://europepmc.org/abstract/MED/12757504

Human parvoviruses

1 reference

https://api.crossref.org/works/10.1046%2FJ.1423-0410.2003.00299.X

21 January 2018

Parvovirus B19 infection and hematopoiesis

1 reference

https://api.crossref.org/works/10.1046%2FJ.1423-0410.2003.00299.X

21 January 2018

Human parvovirus B19: relevance in internal medicine.

1 reference

https://api.crossref.org/works/10.1046%2FJ.1423-0410.2003.00299.X

21 January 2018

Clinical and laboratory findings in immunocompetent patients with persistent parvovirus B19 DNA in bone marrow

1 reference

https://api.crossref.org/works/10.1046%2FJ.1423-0410.2003.00299.X

21 January 2018

An outbreak of erythema infectiosum associated with human parvovirus infection

1 reference

https://api.crossref.org/works/10.1046%2FJ.1423-0410.2003.00299.X

21 January 2018

Chronic anemia due to parvovirus B19 infection in a bone marrow transplant patient after platelet transfusion

1 reference

https://api.crossref.org/works/10.1046%2FJ.1423-0410.2003.00299.X

21 January 2018

Pasteurization of antihemophilic factor and model virus inactivation studies

1 reference

https://api.crossref.org/works/10.1046%2FJ.1423-0410.2003.00299.X

21 January 2018

Parvoviruses and blood products

1 reference

https://api.crossref.org/works/10.1046%2FJ.1423-0410.2003.00299.X

21 January 2018

Blood donor screening for parvovirus B19.

1 reference

https://api.crossref.org/works/10.1046%2FJ.1423-0410.2003.00299.X

21 January 2018

Prevalence of antibodies to human parvovirus B19 nonstructural protein in persons with various clinical outcomes following B19 infection

1 reference

https://api.crossref.org/works/10.1046%2FJ.1423-0410.2003.00299.X

21 January 2018

Establishment of the first World Health Organization International Standard for human parvovirus B19 DNA nucleic acid amplification techniques.

1 reference

https://api.crossref.org/works/10.1046%2FJ.1423-0410.2003.00299.X

21 January 2018

Report of a collaborative study to establish the international standard for parvovirus B19 serum IgG.

1 reference

https://api.crossref.org/works/10.1046%2FJ.1423-0410.2003.00299.X

21 January 2018

Persistent B19 parvovirus infection as a cause of severe chronic anaemia in children with acute lymphocytic leukaemia

1 reference

https://api.crossref.org/works/10.1046%2FJ.1423-0410.2003.00299.X

21 January 2018

Effect of grapefruit juice on blood cyclosporin concentration

1 reference

https://api.crossref.org/works/10.1046%2FJ.1423-0410.2003.00299.X

21 January 2018

Removal of viruses from human intravenous immune globulin by 35 nm nanofiltration

1 reference

https://api.crossref.org/works/10.1046%2FJ.1423-0410.2003.00299.X

21 January 2018

Removal of neutralized model parvoviruses and enteroviruses in human IgG solutions by nanofiltration

1 reference

https://api.crossref.org/works/10.1046%2FJ.1423-0410.2003.00299.X

21 January 2018

Clinical illness due to parvovirus B19 infection after infusion of solvent/detergent-treated pooled plasma

1 reference

https://api.crossref.org/works/10.1046%2FJ.1423-0410.2003.00299.X

21 January 2018

Parvovirus B19: implications for transfusion medicine. Summary of a workshop

1 reference

https://api.crossref.org/works/10.1046%2FJ.1423-0410.2003.00299.X

21 January 2018

Antibodies to the Nonstructural Protein of Parvovirus B19 in Persistently Infected Patients: Implications for Pathogenesis

1 reference

https://api.crossref.org/works/10.1046%2FJ.1423-0410.2003.00299.X

21 January 2018

Chronic parvovirus B19 infection and systemic necrotising vasculitis: opportunistic infection or aetiological agent?

1 reference

https://api.crossref.org/works/10.1046%2FJ.1423-0410.2003.00299.X

21 January 2018

Parvovirus B19 DNA in plasma pools and plasma derivatives

1 reference

https://api.crossref.org/works/10.1046%2FJ.1423-0410.2003.00299.X

21 January 2018

Human parvovirus B19: prevalence of viral DNA in volunteer blood donors and clinical outcomes of transfusion recipients

1 reference

https://api.crossref.org/works/10.1046%2FJ.1423-0410.2003.00299.X

21 January 2018

High-titer screening PCR: a successful strategy for reducing the parvovirus B19 load in plasma pools for fractionation

1 reference

https://api.crossref.org/works/10.1046%2FJ.1423-0410.2003.00299.X

21 January 2018

Identifiers

10.1046/J.1423-0410.2003.00299.X

1 reference

Europe PubMed Central

PubMed publication ID

19 April 2018

http://europepmc.org/abstract/MED/12757504

PubMed publication ID

1 reference

Europe PubMed Central

PubMed publication ID

19 April 2018

http://europepmc.org/abstract/MED/12757504

Sitelinks

Wikipedia(0 entries)

Wikibooks(0 entries)

Wikinews(0 entries)

Wikiquote(0 entries)

Wikisource(0 entries)

Wikiversity(0 entries)

Wikivoyage(0 entries)

Wiktionary(0 entries)

Multilingual sites(0 entries)

Retrieved from "https://www.wikidata.org/w/index.php?title=Q52016510&oldid=1364268594"